| Disease |
Protein |
BMRB entry |
| Alzheimer's disease |
Amyloid peptide Abeta (1-40) |
5057
6257
17159
17764
17795
17796 |
|
Amyloid peptide Abeta (1-42) |
5400
17793
17794 |
|
Amyloid precursor protein APP |
4342 |
|
Anomalous copper(II) binding to Abeta peptide |
17186 |
|
Apolipoprotein E |
15744 |
|
Beta-amyloid |
15775
18052
18127
18128
18131
18175
19009 |
|
Beta-amyloid modulated by congo red |
26516 |
|
Beta-amyloid modulated by lacmoid |
26508 |
|
Beta-amyloid precursor transmembrane domain |
18080
18648
18649 |
|
Calcium-bound human S100B |
5206 |
|
CAPPD* domain of human APP770 |
6236 |
|
Complement repeat 56 / Receptor associated protein complex |
17055 |
|
Kunitz-Type inhibitor domain of APP |
2024 |
|
Tau protein |
17945 |
| Amyotrophic lateral sclerosis |
Angiogenin |
18197 |
|
apo-SOD1 |
15711 |
|
apo-SOD1-variant A4V |
15712 |
|
apo-SOD1-variant D90A |
15714 |
|
apo-SOD1-variant G85R |
15713 |
|
Cu(I), Zn(II) superoxide dismutase |
18509 |
|
SOD1 monomer |
26570 |
| Charcot-Marie Tooth Disease |
Human TrJ disease-related mutant form of PMP22 |
17455 |
|
Mediator complex subunit 25 (391-543) |
17323 |
|
Peripheral myelin protein 22 |
17454 |
| Creutzfeldt-Jakob disease |
Human prion protein with E219K polymorphism |
18426 |
|
Human prion protein V210I mutant |
18550 |
| Early Onset Neurodegeneration |
Iowa-mutant B-amyloid fibrils |
17774 |
| Epilepsy |
Human membrane protein TMEM14A |
18219
18222 |
| Friedreich Ataxia |
Frataxin |
4342 |
| Holoprosencephaly |
Homeobox domain (171-248) |
17971 |
| Huntington's Disease |
N-terminal domain of huntingtin (htt17) |
17642
17644 |
| Juvenile Parkinson's Disease |
IBR Domain |
15074 |
|
Parkin RING 2 |
18642 |
|
Parkin Ubl domain/Endophilin-A1 SH3 domain complex |
16813 |
| Machado-Joseph Disease |
Ataxin-3 |
17333 |
| Multiple sclerosis |
Myelin basic protein with DPC micelles |
18520 |
|
Myelin basic protein |
6100
6857
15131
20062
|
| Parkinson's Disease |
A30P alpha-synuclein fibrils |
17214
17648 |
|
A53T alpha-synuclein fibrils |
17649 |
|
Alpha-synuclein fibril mutation A53T and E46K |
18207
18208
18232
18243 |
|
Alpha-synuclein fibrils |
16904
16939
17910 |
|
Disordered alpha-synuclein variants |
16543
16546
16547
16548 |
|
DJ-1 |
17507 |
|
E46K alpha-synuclein fibrils |
17654 |
|
N-terminal domain of human cerebral dopamine neurotrophic factor |
18269 |
|
SH3 domains of BAR protein |
16813 |
|
Ubiquitin carboxy-terminal hydrolase L1 |
17260 |
|
Ubiquitin like domain in Parkin |
5496
5500 |
| Vestibular Neuronitis |
Brain acid soluble protein 1 |
18417 |
| Williams syndrome |
DnaJ domain |
11144 |
|
WSTF-Phd Zinc finger |
4928 |
| Rett Syndrome |
Zinc finger protein Kaiso |
18462 |
|
PTP1B |
25375 |
| Spinal Muscular Atrophy |
R3H domain of human Smubp-2 |
18391 |
|
Tudor domain of human SMN protein |
18005
18006
18007
18008 |
| Spinocerebellar Ataxia 28 |
AFG3-like protein 2 |
18156 |
| Wilson disease |
Apo Wilson Copper Binding Domain 4-6 |
16937 |
|
ATX1 Antioxidant Protein 1 Homolog |
18299 |
|
E1064A mutant of Wilson Disease Protein |
16536 |
|
Human copper transporter 1 |
18408
18409
18410 |
|
Metal Binding Domains 3,4 of Wilson disease protein |
11041 |
|
N-domain of Wilson disease protein |
16761 |
| Wolff-Parkinson-White syndrome |
AMP-activated protein kinase alpha 2 catalytic subunit |
18497 |
